These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 347003)

  • 1. Human leukocyte inhibitory factor (LIF): use of benzoyl L-arginine ethyl ester to detect LIF activity.
    Rocklin RE; Urbano AM
    J Immunol; 1978 Apr; 120(4):1409-14. PubMed ID: 347003
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of benzoyl-L-phenylalanyl-L-valyl-L-arginine (3H) methyl ester as a sensitive and selective substrate for the human lymphokine, leukocyte migration inhibitory factor (LIF).
    Bendtzen K; Rocklin RE
    J Immunol; 1980 Oct; 125(4):1775-81. PubMed ID: 6251137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.
    Bendtzen K
    Scand J Immunol; 1977; 6(10):1055-62. PubMed ID: 335493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte inhibitory factor (LIF): a lymphocyte mediator with esteratic properties.
    Rocklin R
    Fed Proc; 1978 Nov; 37(13):2743-7. PubMed ID: 710595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
    Bendtzen K
    J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that human leukocyte inhibitory factor (LIF) is an esterase.
    Rocklin RE; Rosenthal AS
    J Immunol; 1977 Jul; 119(1):249-52. PubMed ID: 326958
    [No Abstract]   [Full Text] [Related]  

  • 9. Human leukocyte migration inhibitory factor (LIF). IV. 3',5'-cGMP protects LIF against inactivation by the esterase inhibitor phenylmethylsulfonyl fluoride.
    Bendtzen K
    Scand J Immunol; 1977; 6(12):1357-61. PubMed ID: 203999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stimulation of phagocytic function by factors inhibiting leukocyte and macrophage migration in humans].
    Gankovskaia LV; Tskhovrebova AZ; Gvozdeva NA; Koval'chuk LV; Cheredeev AN
    Biull Eksp Biol Med; 1986 Aug; 102(8):210-3. PubMed ID: 3527300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on tuberculin hypersensitivity--immunological significance of leucocyte migration inhibitory factor (LIF) and macrophage migration inhibitory factor (MIF) (author's transl)].
    Matsui Y; Oshima S
    Kekkaku; 1979 Jun; 54(6):331-44. PubMed ID: 388018
    [No Abstract]   [Full Text] [Related]  

  • 15. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on leukocyte migration inhibitory factor (LIF) produced by activated T and B cells.
    Szigeti R; Rosén A
    Lymphokine Res; 1988; 7(1):11-20. PubMed ID: 3283466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of supernatants with high titers of human leukocyte inhibitory factor (LIF).
    McCoy JL; Braatz JA; Ames RS; Herberman RB
    J Immunol; 1980 Jun; 124(6):2786-93. PubMed ID: 6989906
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF).
    Cruikshank W; Center DM
    J Immunol; 1982 Jun; 128(6):2569-74. PubMed ID: 7042841
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential effect of interferon on the production on virus- and mitogen-induced leukocyte inhibitory factors in human leukocyte cultures.
    Dinh PN; Rosztóczy I; Béládi I; Tóth M
    Acta Virol; 1980 Dec; 24(6):427-32. PubMed ID: 6163345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).
    Kniep EM; Domzig W; Lohmann-Matthes ML; Kickhöfen B
    J Immunol; 1981 Aug; 127(2):417-22. PubMed ID: 6166671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.